StockData
MKS Inc logo

MKS Inc (MKSI) stock analysis

MKSINasdaqIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/303% below fair value
$204.38−11.27 (-5.23%)

Close on Nov 16, 2026Market cap $13.82BP/E 32.6Yield 0.43%

StockData Score

Prices as of Nov 16, 2026How the score works

Value2Growth3Performance4Health2Dividend4

Solid15 of 30 checks passed

MKS passes 15 of the 30 checks behind our score. Each dot in the shape is one check — hover it for the numbers.

Valuation
2/6
Growth
3/6
Past performance
4/6
Financial health
2/6
Dividend
4/6

What stands out

  • Trading below fair value

    The share price of $204.38 is below our fair value estimate of $211.51.

  • Return on capital over 10%

    Return on invested capital was 20.3%, above the 10% that usually covers the cost of capital.

  • Earnings growth accelerating

    Net income grew 64.8% over the last twelve months, against a 5-year average of -3.4% a year.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 45.4% of total debt.

What to watch

  • Margin of safety under 20%

    The price is 3.4% below fair value, less than the 20% cushion we look for.

  • Return on equity under 15%

    Return on equity was 15.9% over the last twelve months and averaged -0.7% over five years; we look for 15% on both.

  • High debt

    Debt is 46.8% of shareholders' equity, above the 40% we consider low.

  • Earnings shrank over 5 years

    Net income shrank 3.4% a year on average over the last five fiscal years.

Valuation2/6
  • P/E above its 5-year median

    MKS's P/E of 32.6 is above its own 5-year median of 29.6.

  • P/E below the industry

    MKS's P/E of 32.6 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.1.

  • EV/EBITDA above its 5-year median

    MKS's EV/EBITDA of 14.4 is above its 5-year median of 9.4.

  • P/B above the industry

    MKS's price-to-book of 4.63 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.10.

  • Trading below fair value

    The share price of $204.38 is below our fair value estimate of $211.51.

  • Margin of safety under 20%

    The price is 3.4% below fair value, less than the 20% cushion we look for.

Growth3/6
  • Revenue growing under 10% a year

    Revenue grew 3.5% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -7.7% a year over the last three fiscal years.

  • Earnings growth accelerating

    Net income grew 64.8% over the last twelve months, against a 5-year average of -3.4% a year.

  • Growing faster than the industry

    Revenue grew 16.3% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.

  • Guidance raised

    MKS raised its Fourth Quarter 2026 Non-GAAP net earnings outlook on Nov 4, 2026.

  • Gross margin slipping

    Gross margin was 47.0% over the last twelve months, against 47.3% a year earlier.

Past performance4/6
  • Return on equity under 15%

    Return on equity was 15.9% over the last twelve months and averaged -0.7% over five years; we look for 15% on both.

  • Return on capital over 10%

    Return on invested capital was 20.3%, above the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    MKS's return on equity of 15.9% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.4%.

  • Earnings shrank over 5 years

    Net income shrank 3.4% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 10.1% over the last twelve months, against a 5-year average of -2.0%.

  • Net margin above the industry

    MKS's net margin of 10.1% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.5%.

Financial health2/6
  • High debt

    Debt is 46.8% of shareholders' equity, above the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 0.6% five years ago to 46.8%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 45.4% of total debt.

  • Interest not well covered

    Operating income covers interest expense 3.7 times; we look for at least 5.

  • Short-term assets cover short-term debts

    Current assets are 1.14 times current liabilities.

  • Bankruptcy risk in the grey zone

    The Altman Z-score is 2.32; above 3 is the safe zone and below 1.8 the distress zone.

Dividend4/6
  • Pays a dividend

    MKS paid dividends worth 0.5% of the share price over the last twelve months.

  • Yield below Treasuries

    The 0.5% yield is below the 4.7% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.9% or more; MKS yields 0.5%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Covered by earnings

    Dividends take 14.3% of net income.

  • Covered by free cash flow

    Dividends take 13.8% of free cash flow.

Scores of similar companies

Our estimate per share

$211.51

The share price is 3% below this estimate.

20%+ below
Near fair value
20%+ above
$204.38Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E32.8×29.6×36.1×$205.4447%
EV/EBITDA16.8×9.4×24.4×$240.5341%
P/B3.0×3.0×3.1×$134.1712%
Earnings powerleft out, too far from the others15.2% cost of equity––$37.06–
Fair value$211.51100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 29.6
  • Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.1

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$334.09M
Value traded per 1% price move
$107.92M

Downside

High risk

Typical loss in a bad month
29.8%
Volatility (annualized)
63%
Sharpe ratio, 1 year
0.59
Beta to the S&P 500 (5Y)
2.17

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

46.7%+1.7 pts over 5 years

Operating margin

13.4%−6.1 pts over 5 years

Net margin

7.5%−7.5 pts over 5 years

See a number that looks wrong?